Comparison of the dissolution of metaxalone tablets (Skelaxin) using USP Apparatus 2 and 3.
The purpose of this study was to evaluate the effect of pH on the dissolution behavior of metaxalone in the marketed product Skelaxin tablets. The dissolution was evaluated using United States Pharmacopeia (USP) dissolution Apparatus 2 and 3 at pHs ranging from 1.5 to 7.4. Results from these studies show that the dissolution of this product is pH dependent. At low pH (simulated gastric fluid, pH 1.5), the dissolution of metaxalone from Skelaxin tablets was less than 10% over 75 minutes; whereas, dissolution at pH 4.5 showed greater than 90% release in the same time period. These results were consistent for both Apparatus 2 and 3. This suggests that Skelaxin Tablets should be considered a delayed release dosage form.
Cacace
Janice
J
Nova Southeastern University, College of Pharmacy, 3200 South University Drive, Ft Lauderdale, FL 33328-2018, USA. jcacace@nova.edu
Reilly
Eugene E
EE
Amann
Anton
A
D003692:Delayed-Action Preparations; D006863:Hydrogen-Ion Concentration; D023303:Oxazolidinones / Q000008:administration & dosage / Q000737:chemistry*; D012995:Solubility; D013607:Tablets / Q000008:administration & dosage / Q000737:chemistry*; D013678:Technology, Pharmaceutical
D003692:Delayed-Action Preparations; D023303:Oxazolidinones; D013607:Tablets; C011301:metaxalone